GlaxoSmithKline’s new CEO Emma Walmsley is set to outline her vision for the company alongside half-year results next month – but reports suggest that she may shake up the consumer products
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
